[Federal Register Volume 61, Number 168 (Wednesday, August 28, 1996)]
[Notices]
[Pages 44314-44315]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-21898]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Cancer Institute; Notice of Meetings of the National 
Cancer Advisory Board and its Subcommittee

    Pursuant to Pub. L. 92-463, notice is hereby given of the meeting 
of the National Cancer Advisory Board, National Cancer Institute, and 
its Subcommittees on September 10-11, 1996. Except as noted below, the 
meetings of the Board and its Subcommittees will be open to the public 
to discuss issues relating to committee business as indicated in the 
notice. Attendance by the public will be limited to space available.
    A portion of the Board meeting will be closed to the public in 
accordance with the provisions set forth in secs. 552b(c)(4), 
552b(c)(6), and 552(c)(9)(B), Title 5, U.S.C. and sec. 10(d) of Pub. L. 
92-463, for the review, discussion and evaluation of individual grant 
applications and for discussion of issues pertaining to programmatic 
areas and/or NCI personnel, and discussion of subcommittee 
recommendations regarding NCI staff support to the Board and operating 
procedures. These applications and discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material, and personal information concerning the individuals 
associated

[[Page 44315]]

with the applications or programs, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy and 
premature disclosure of recommendations which would inhibit the final 
outcome and subsequent implementation of recommendations.
    The Committee Management Office, National Cancer Institute, 
National Institutes of Health, Executive Plaza North, Room 630E, 9000 
Rockville Pike, Bethesda, Maryland 20892 (301/496-5708), will provide 
summaries of the meetings and rosters of the Board members, upon 
request.
    Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
contact Ms. Carole Frank, Committee Management Specialist, at 301/496-
5708 in advance of the meeting.

    Name of Committee: National Cancer Advisory Board.
    Contact Person: Dr. Marvin R. Kalt, Executive Secretary, 
National Cancer Institute, NIH, Executive Plaza North, Room 600A, 
6130 Executive Blvd., Bethesda, MD 20892-7405; (301) 496-5147.
    Dates of Meeting: September 10-11, 1996.
    Place of Meeting: Conference Room 10, Building 31C, National 
Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892.
    Open: September 10--8 am to approximately 12:15 pm.
    Agenda: Director's Report on the National Cancer Institute; NCI 
Strategic Planning and Evaluation Structure; NCAB: 25th Anniversary 
Initiatives; New Business; Scientific Presentations; and Report on 
the Activities of the President's Cancer Panel.
    Closed: September 10--2:30 pm to approximately 4:30 pm.
    Agenda: For review and discussion of individual grant, 
applications, and extramural/intramural programmatic, and personnel 
policies.
    Open: September 11--8:30 am to 11 am.
    Agenda: Scientific Presentations: Subcommittee Reports; Report 
on the NCAB Retreat; Peer Review Initiatives; Continuing New 
Business.
    Closed: September 11--11 am to 4:30 pm.
    Agenda: Review and evaluation of NCAB staff support, structure 
and function.

    Name of Committee: Subcommittee on Clinical Investigations.
    Contact Person: Dr. Robert Wittes, Executive Secretary, National 
Cancer Institute, NIH, Building 31, Room 3A44, Bethesda, MD 20892; 
(301) 496-4291.
    Date of Meeting: September 10, 1996.
    Place of Meeting: Conference Room 7, Building 31C, National 
Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892.
    Open: 12:30 pm to 1:30 pm.
    Agenda: To discuss the By Pass Budget and translational research 
as well as the possibilities for allocating NCI dollars to defray 
clinical costs.
    Name of Committee: Subcommittee on Planning and Budget.
    Contact Person: Ms. Cherie Nichols, Executive Secretary, 
National Cancer Institute, NIH, Building 31, Room 11A19, Bethesda, 
MD 20892; (301) 496-5515.
    Date of Meeting: September 10, 1996.
    Place of Meeting: Conference Room 9, Building 31C, National 
Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892.
    Open: 12:30 pm to 1:30 pm.
    Agenda: To discuss the NCI budget and various planning issues.

    This notice is being published less than 15 days prior to the 
meeting due to the urgent need to meet timing limitations imposed by 
the review and funding cycle.

(Catalog of Federal Domestic Assistance Program Numbers: 93.393, 
Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, 
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
Cancer Research Manpower; 93.399, Cancer Control)

    Dated: August 22, 1996.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 96-21898 Filed 8-27-96; 8:45 am]
BILLING CODE 4140-01-M